Sign in
8-K

Current Report

Viridian Therapeutics, Inc.DE Filed Acc 0001590750-21-000013

Executive or director change · Bylaws or fiscal year change · Other events

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading vrdn-20210115.htm…